Clinical trial

Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage

NCT00119080 · Centers for Disease Control and Prevention, U.S. Fed · Completed

Key facts

NCT number NCT00119080
Title Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage
Official title Evaluation of the Effect of Tetravalent (A, C, Y, W-135) Meningococcal Conjugate Vaccine on Serogroup-Specific Carriage of Neisseria Meningitidis
Lead sponsor Centers for Disease Control and Prevention, U.S. Fed
Collaborators Georgia Department of Human Resources Maryland Department of Health and Mental Hygiene Johns Hopkins University University of Pittsburgh
Status Completed
Phase Phase 4
Study type Interventional
Conditions Meningitis
Intervention type Biological
Interventions meningococcal conjugate vaccine (Menactra)
Enrollment 4,000
Start date Aug 1, 2006
Completion May 1, 2007
First posted Jul 13, 2005
Last update posted Mar 19, 2007

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies